Chancellor Rachel Reeves Plans Focused Action on Household Expenses in Forthcoming Financial Plan
Chancellor Rachel Reeves has revealed she is preparing "focused action to tackle household expense challenges" in the upcoming Budget.
During an interview with the BBC, she emphasized that reducing price rises is a shared responsibility of both the government and the central bank.
The United Kingdom's price growth is projected to be the highest among the Group of Seven developed nations this calendar year and the following year.
Potential Utility Bill Measures
It is understood the government could take action to lower energy bills, for example by cutting the current 5% rate of VAT charged on energy.
A further possibility is to lower some of the regulatory levies presently included in bills.
Budgetary Constraints and Analyst Expectations
The administration will obtain the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will reveal how much space there is for these measures.
The view from the majority of economists is that the Chancellor will have to declare tax rises or spending cuts in order to fulfill her voluntary debt limits.
Earlier on Thursday, analysis indicated there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the lower end of forecasts.
"There's a shared task between the Bank of England and the administration to continue tackling some of the causes of price increases," Reeves informed reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.
Tax Pledges and International Concerns
While a great deal of the focus has been on likely tax rises, the Treasury chief said the latest data from the fiscal watchdog had not changed her commitment to manifesto promises not to raise rates on earnings tax, VAT or National Insurance.
She blamed an "unpredictable world" with growing international and trade tensions for the Budget tax moves, likely to be focused on those "wealthiest."
International Trade Tensions
Addressing apprehensions about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security invariably are paramount."
Last week's announcement by China to tighten export controls on rare earths and other resources that are key for advanced tech production led American leader the US President to propose an further 100% tariff on goods from China, increasing the prospect of an all-out commercial conflict between the two largest economies.
The US Treasury Secretary called the Chinese action "commercial pressure" and "a global supply chain control attempt."
Questioned on considering the American proposal to join its dispute with China, the Chancellor said she was "deeply worried" by China's measures and called on the Beijing authorities "to avoid restrictions and restrict access."
She said the action was "harmful for the international commerce and causes additional obstacles."
"It is my opinion there are areas where we should address China, but there are also significant chances to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that balance right."
The chancellor also affirmed she was collaborating with other major economies "on our own critical minerals plan, so that we are more independent."
NHS Medicine Pricing and Funding
The Chancellor also admitted that the price the National Health Service pays for medicines could go up as a result of current negotiations with the US government and its pharmaceutical firms, in return for lower tariffs and investment.
A number of the biggest global pharmaceutical manufacturers have said lately that they are either halting or scrapping operations in the United Kingdom, with several attributing the insufficient payments they are obtaining.
Last month, the Science Minister said the cost the health service spends on drugs would have to increase to halt businesses and drug research funding leaving the United Kingdom.
Reeves stated to media: "It has been observed due to the cost structure, that drug testing, innovative medicines have not been offered in the UK in the manner that they are in other European countries."
"We want to ensure that people getting treatment from the National Health Service are able to receive the best life-saving drugs in the world. And so we are examining these issues, and... looking to attract additional capital into the UK."